Trending:
-
23 April 2018
Pfizer funds CreakyJoints’ initiative for shared decision making in rheumatoid arthritis
In a landmark moment for rheumatoid arthritis (RA) treatment, Pfizer has joined forces with CreakyJoints, an online patient advocacy group, in an initiative to improve shared decision making about treatment...
-
23 April 2018
World Immunisation Week 2018: WHO spotlights remaining vaccine coverage gaps
Each year, the World Health Organization (WHO) uses World Immunisation Week during the last week of April to promote awareness of the countless benefits of vaccines, which are undeniably the...
-
19 April 2018
Pharma Technology Focus – Issue 70
In this issue: A toolkit to enhance the user experience for life sciences, the problem of unapproved antibiotics in India, a new taxonomy for traditional Chinese medicine, inside Canada’s Centre...
-
12 April 2018
Rebiotix acquisition solidifies Ferring’s position in the microbiome space
On 5 April, Ferring Pharmaceuticals announced its acquisition of Rebiotix, a clinical-stage biotech focused on the development of microbiome-based therapeutics.
-
9 April 2018
How long will infliximab biosimilars dominate the US anti-TNF market?
A trial due to start later this month to determine whether Sandoz can launch Erelzi prior to patent expiry of Amgen’s anti-tumor necrosis factor Enbrel appears to have been delayed...
-
6 April 2018
Tetra granted FDA Orphan Drug Designation for FXS treatment, but will it be enough?
BPN14770, which is being developed by Tetra Discovery Partners for the treatment of Fragile X syndrome (FXS), was granted Orphan Drug Designation by the FDA on 3 April.
-
5 April 2018
Microbiome-targeted immunotherapies: getting the pricing right
The development of microbiome-targeted therapeutics for the treatment of gastrointestinal indications has become a hot area in the immunology space in recent years, with the potential to introduce an innovative...
-
3 April 2018
Pfizer’s pipeline specialisation
In early 2018 Pfizer announced it would be ending its neuroscience discovery program.
-
3 April 2018
Pharma Technology Focus – Issue 69
In this issue: The world’s pharma manufacturing hotspots, creating a universal flu vaccine, obstacles to improving the treatment of Alzheimer’s disease, the potential of growth drugs, detecting racemisation in drugs,...
-
28 March 2018
A step towards earlier detection of Parkinson’s disease
Alpha-synuclein imaging agents to help detect Parkinson’s disease will progress to human studies later this year.
